#Mesoblast Allogeneic Cell Therapy Products Are Designated U.S. Country of Origin and Not Subject to U.S. Tariffs

Currently there are 33 navarras companies installed in this country

Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab

Mesoblast (ASX:MSB) shares have fallen just shy of -3% heading into lunchtime trades, even as the company said it “believes” its stem cell products aren’t subject to U.S. tariffs. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. For some users on HotCopper, the word “belief” wasn’t quite certain enough. Indeed, perhaps that ambiguous language…

#Mesoblast Allogeneic Cell Therapy Products Are Designated U.S. Country of Origin and Not Subject to U.S. Tariffs

Mesoblast's Strategic Advancement: U.S. Tariff Exemption and Medical Designations Propel Innovative Cell Therapies 'New York, April 03, 2025' '' In a dual win for Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global frontrunner in the advancement of allogeneic cellular medicines for inflammatory diseases, significant strides have been made concerning the company's flagship products amid dynamic regulatory landscapes. While the company elucidates t…